- Home
- LINE vs BPMC Comparison
LINE vs BPMC Comparison
Compare LINE & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINE
- BPMC
- Stock Information
- Founded
- LINE 2012
- BPMC 2008
- Country
- LINE United States
- BPMC United States
- Employees
- LINE N/A
- BPMC N/A
- Industry
- LINE
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- LINE
- BPMC Health Care
- Exchange
- LINE NYSE
- BPMC Nasdaq
- Market Cap
- LINE 10.0B
- BPMC 8.3B
- IPO Year
- LINE 2024
- BPMC 2015
- Fundamental
- Price
- LINE $42.32
- BPMC $129.32
- Analyst Decision
- LINE Buy
- BPMC Buy
- Analyst Count
- LINE 18
- BPMC 20
- Target Price
- LINE $66.72
- BPMC $127.82
- AVG Volume (30 Days)
- LINE 940.9K
- BPMC 3.3M
- Earning Date
- LINE 08-06-2025
- BPMC 07-31-2025
- Dividend Yield
- LINE 4.91%
- BPMC N/A
- EPS Growth
- LINE N/A
- BPMC N/A
- EPS
- LINE N/A
- BPMC N/A
- Revenue
- LINE $5,302,000,000.00
- BPMC $562,121,000.00
- Revenue This Year
- LINE $4.01
- BPMC $44.46
- Revenue Next Year
- LINE $4.81
- BPMC $32.78
- P/E Ratio
- LINE N/A
- BPMC N/A
- Revenue Growth
- LINE N/A
- BPMC 99.19
- 52 Week Low
- LINE $41.88
- BPMC $73.04
- 52 Week High
- LINE $89.85
- BPMC $129.49
- Technical
- Relative Strength Index (RSI)
- LINE N/A
- BPMC 76.79
- Support Level
- LINE N/A
- BPMC $128.06
- Resistance Level
- LINE N/A
- BPMC $129.49
- Average True Range (ATR)
- LINE 0.00
- BPMC 0.27
- MACD
- LINE 0.00
- BPMC -0.97
- Stochastic Oscillator
- LINE 0.00
- BPMC 87.41
About LINE LINEAGE INC
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.